IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)



Status:Recruiting
Conditions:Premature Ejaculation, Women's Studies
Therapuetic Areas:Nephrology / Urology, Reproductive
Healthy:No
Age Range:18 - 60
Updated:4/1/2017
Start Date:February 28, 2017
End Date:December 1, 2017
Contact:Ixchelsis Limited
Email:info@ixchelsis.com
Phone:0 11 44 1304892397

Use our guide to learn which trials are right for you!

A Phase 2b, 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of 3 Different Dose Levels of IX-01 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (PE)

A Phase 2b, 8-week, double-blind, placebo-controlled, parallel group study to evaluate the
effect of 3 different dose levels of IX-01 on IELT and patient-reported outcome in men with
lifelong PE.

Men with self-reported lifelong PE (International Society for Sexual Medicine (ISSM)
definition) and in stable heterosexual relationship will undergo a 4-week run-in period
during which they will be asked to attempt intercourse at least 4 times. Men with IELT ≤ 1
minute on at least 75% of attempts at intercourse during the no-treatment run-in period will
be randomized for the double-blind phase of the study.

In the double-blind phase of the study, men will be asked to take study drug 1 to 6 hours
prior to sexual activity. Men and partners will be asked to attempt intercourse a minimum of
8 times during the 8 week double-blind study treatment. The patient or partner will record
the IELT on each occasion by use of a stopwatch.


Inclusion Criteria:

1. Men aged ≥18 years and ≤60 years in stable (≥6 months) heterosexual relationship and
who have lifelong PE.

2. Premature ejaculation ≤1 minute on ≥75% attempts at sexual intercourse during the
run-in period.

3. Meets other aspects of ISSM definition.

4. Patient and partner willing to attempt intercourse at least 4 times during the run-in
period and at least 8 additional times during the double-blind part of the study.

5. Partner not planning pregnancy and willing to use contraception (unless not of
childbearing potential, e.g, surgically sterilized).

6. Willing to limit use of alcohol on days in which he takes study drug.

7. Capable of giving written informed consent.

Exclusion Criteria:

1. IELT value >2 minutes during the run-in period.

2. <4 attempts at sexual intercourse during the run-in period.

3. Any patient who rates his control of ejaculation as fair, good, or very good.

4. Any patient who rates his ejaculation-related "personal distress" as "not at all" or
"a little bit".

5. Erectile Dysfunction.

6. Concomitant use of phosphodiesterase type 5 (PDE5) inhibitors, selective serotonin
reuptake inhibitor (SSRIs)/selective serotonin norepinephrine reuptake inhibitor
(SSNRIs), monoamine oxidase inhibitors, alpha blockers, 5-alpha reductase inhibitors,
topical anesthetics, and/or tramadol.

7. History (last 6 months) of use of Botox or similar product to treat PE.

8. Has received IX-01 in a previous clinical study.

9. Unwilling to stop other treatments for PE (including but not limited to
pharmacological, sex therapy, psychotherapy multiple condoms, and prior
masturbation).

10. Any other sexual disorder of patient or partner that could interfere with results.

11. Any current sexually transmitted disease.

12. Any major medical condition of patient that could interfere with ability to have
sexual activity and/or require hospital treatment.

13. Body mass index (BMI) >40 kg/m2 or weight <60 kg.

14. Participation in a clinical drug study anytime during the 30 days prior to screening.

15. Human immunodeficiency virus (HIV), hepatitis B.

16. History of prostate disease or clinically significant prostate disease.

17. History of myocardial infarction, coronary bypass surgery, coronary artery
angioplasty, unstable angina, clinically evident congestive heart failure, cardiac
pacemaker, or cerebrovascular accident.

18. Known or suspected history of significant cardiac arrhythmias.

19. History of drug-induced allergic reactions including skin reactions.

20. Significant psychiatric disease and/or risk of suicidal tendency.

21. History of or other evidence of recent alcohol or drug abuse.
We found this trial at
28
sites
1275 Olentangy River Road
Columbus, Ohio 43212
614-294-3854
?
mi
from
Columbus, OH
Click here to add this to my saved trials
530 South Main Street
Akron, Ohio 44311
330-252-1500
?
mi
from
Akron, OH
Click here to add this to my saved trials
552-A Memorial Drive Extension
Greer, South Carolina 29651
864-877-9239
?
mi
from
Greer, SC
Click here to add this to my saved trials
8122 Datapoint Drive
San Antonio, Texas 78229
210-614-7483
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Anderson, South Carolina 29621
?
mi
from
Anderson, SC
Click here to add this to my saved trials
Aventura, Florida 33180
?
mi
from
Aventura, FL
Click here to add this to my saved trials
Bala Cynwyd, Pennsylvania 19004
?
mi
from
Bala Cynwyd, PA
Click here to add this to my saved trials
Boston, Massachusetts 02135
?
mi
from
Boston, MA
Click here to add this to my saved trials
2081 West Frye Road
Chandler, Arizona 85224
?
mi
from
Chandler, AZ
Click here to add this to my saved trials
Chestnut Hill, Massachusetts 02467
?
mi
from
Chestnut Hill, MA
Click here to add this to my saved trials
Cincinnati, Ohio 45249
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dallas, Texas 75231
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Garden City, New York 11530
?
mi
from
Garden City, NY
Click here to add this to my saved trials
Hartsdale, New York 10530
?
mi
from
Hartsdale, NY
Click here to add this to my saved trials
900 West 49th Street
Hialeah, Florida 33012
?
mi
from
Hialeah, FL
Click here to add this to my saved trials
Kansas City, Missouri 64114
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
2481 Professional Court
Las Vegas, Nevada 89128
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
2310 East Brown Road
Mesa, Arizona 85213
?
mi
from
Mesa, AZ
Click here to add this to my saved trials
Mobile, Alabama 36608
?
mi
from
Mobile, AL
Click here to add this to my saved trials
5251 South Green Street
Murray, Utah 84123
?
mi
from
Murray, UT
Click here to add this to my saved trials
New York, New York 10016
?
mi
from
New York, NY
Click here to add this to my saved trials
4350 East Camelback Road
Phoenix, Arizona 85018
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pompano Beach, Florida 33060
?
mi
from
Pompano Beach, FL
Click here to add this to my saved trials
Providence, Rhode Island 02906
?
mi
from
Providence, RI
Click here to add this to my saved trials
Roswell, Georgia 30076
?
mi
from
Roswell, GA
Click here to add this to my saved trials
San Antonio, Texas 78229
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Diego, California 92120
?
mi
from
San Diego, CA
Click here to add this to my saved trials
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials